M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

Event-Driven

<p>Spectranetics Corp. is expected to receive Food and Drug Administration approval this summer for its drug-coated balloon catheter used to treat peripheral artery disease (PAD), makingthe company an attractive takeover target, sources told CTFN.</p>

Spectranetics Corp. is expected to receive Food and Drug Administration approval this summer for its drug-coated balloon catheter used to treat peripheral artery disease (PAD), makingthe company an attractive takeover target, sources told CTFN.

Spectranetics Nearing Expected FDA Approval of Stellarex